Testing effectiveness (Phase 2)Ended earlyNCT05237284
What this trial is testing
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Who this might be right for
Amyotrophic Lateral Sclerosis
Sanofi 305
Showing 20 of 0 results